{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:40:35Z","timestamp":1791520835993,"version":"4.3.4"},"reference-count":28,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"DOI":"10.1210\/jc.2016-3821","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T15:09:55Z","timestamp":1492614595000},"page":"2039-2043","source":"Crossref","is-referenced-by-count":18,"title":["Effect of Moxonidine on the Aldosterone\/Renin Ratio in Healthy Male Volunteers"],"prefix":"10.1210","volume":"102","author":[{"given":"Ashraf H.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett C.","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus P.","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"issue":"4","key":"key\n\t\t\t\t20170606140009_B1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"key\n\t\t\t\t20170606140009_B2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20170606140009_B3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00045415-199907000-00012","article-title":"Primary aldosteronism: a common and curable form of hypertension","volume":"7","year":"1999","journal-title":"Cardiol Rev"},{"issue":"8","key":"key\n\t\t\t\t20170606140009_B4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key\n\t\t\t\t20170606140009_B5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","year":"2007","journal-title":"Hypertension"},{"issue":"9","key":"key\n\t\t\t\t20170606140009_B6","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20170606140009_B7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","year":"2016","journal-title":"Physiol Rev"},{"issue":"6","key":"key\n\t\t\t\t20170606140009_B8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","year":"2002","journal-title":"Hypertension"},{"issue":"4","key":"key\n\t\t\t\t20170606140009_B9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key\n\t\t\t\t20170606140009_B10","first-page":"457","article-title":"Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis","volume":"82","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20170606140009_B11","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/clpt.1980.221","article-title":"Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney","volume":"28","year":"1980","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"key\n\t\t\t\t20170606140009_B12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key\n\t\t\t\t20170606140009_B13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.ten.0000139006.29471.9e","article-title":"The aldosterone-renin ratio in screening for primary aldosteronism","volume":"14","year":"2004","journal-title":"Endocrinologist"},{"issue":"3","key":"key\n\t\t\t\t20170606140009_B14","first-page":"800","article-title":"Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis","volume":"77","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20170606140009_B15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-73-5-952","article-title":"Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism","volume":"73","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key\n\t\t\t\t20170606140009_B16","first-page":"495","article-title":"Primary aldosteronism","volume":"18","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"key\n\t\t\t\t20170606140009_B17","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI105464","article-title":"A diurnal rhythm in plasma renin activity in man","volume":"45","year":"1966","journal-title":"J Clin Invest"},{"issue":"2","key":"key\n\t\t\t\t20170606140009_B18","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1210\/jc.2010-1355","article-title":"Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20170606140009_B19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200402000-00006","article-title":"The challenge of more robust and reproducible methodology in screening for primary aldosteronism","volume":"22","year":"2004","journal-title":"J Hypertens"},{"issue":"9","key":"key\n\t\t\t\t20170606140009_B20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps","volume":"52","year":"2006","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"key\n\t\t\t\t20170606140009_B21","first-page":"113","article-title":"Determination of aldosterone in serum by liquid chromatography\u2013tandem mass spectrometry","volume":"862","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"key\n\t\t\t\t20170606140009_B22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC\u2013tandem mass spectrometry","volume":"55","year":"2009","journal-title":"Clin Chem"},{"issue":"5","key":"key\n\t\t\t\t20170606140009_B23","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20170606140009_B24","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1097\/HJH.0b013e32833c2100","article-title":"Effects of moxonidine on sympathetic nerve activity in patients with end-stage renal disease","volume":"28","year":"2010","journal-title":"J Hypertens"},{"issue":"6","key":"key\n\t\t\t\t20170606140009_B25","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF00143521","article-title":"Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension","volume":"5","year":"1991","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12","key":"key\n\t\t\t\t20170606140009_B26","first-page":"1088","article-title":"Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients","volume":"30","year":"2013","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"key\n\t\t\t\t20170606140009_B27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/jcem-34-5-819","article-title":"Plasma aldosterone and renin activity during the menstrual cycle","volume":"34","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20170606140009_B28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1681\/ASN.V132446","article-title":"Variation in the renin angiotensin system throughout the normal menstrual cycle","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/6\/2039\/17665168\/jc.2016-3821.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T17:32:41Z","timestamp":1658943161000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article-lookup\/doi\/10.1210\/jc.2016-3821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,3,16]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3821","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}